Since insulin is prescribed to patients with more advanced diabetes mellitus, an earlier diagnosis of CHD allows for early intervention and the potential early diagnosis of other cardiovascular complications, thus improving their overall survival. This evidence concerns the gene INS and diabetes mellitus.